Current views on apoptosis in theory and medical practice

Polish Journal of Veterinary Sciences

Volumn 6, Issue 1, 2003, Pages 71-80

  Szpringer, E ^a   Lutnicki, K ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Apoptosis; Apoptosis inducing factor (AIF); Bcl 2 genes; Caspases; Cytochrome C; p53; TNF and apoptosis

Indexed keywords

APOPTOSIS INDUCING FACTOR; CASPASE; CYTOCHROME C; OXYGEN RADICAL; PROTEIN BCL 2; PROTEIN P53; TUMOR NECROSIS FACTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; APOPTOSIS; AUTOIMMUNITY; CANCER; CELL ACTIVITY; CELL DEATH; CHRONIC DISEASE; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE FUNCTION; HUMAN; LYMPHOMA; MEDICAL PRACTICE; NERVE DEGENERATION; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN INDUCTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; GENERAL ASPECTS OF DISEASE; IMMUNITY; INFLAMMATION; MEDICINE; NECROSIS; PHYSIOLOGY;

ANIMALS; APOPTOSIS; DISEASE; HUMANS; IMMUNITY; INFLAMMATION; MEDICINE; NECROSIS;

EID: 0038485911     PISSN: 15051773     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (74)

1. Baima B, Stcherling M (2001) Apoptosis in different cutaneous manifestations of lupus erythematosus. Br J Dermatol 144: 958-966.
2. Bartosz G (1995) Metaboliczne efekty stresu oksydacyjnego. In: Druga twarz tlenu. PWN, W-wa: 201-204.
3. Bartosz G (1995) Reaktywne formy tlenu jako mediatory i regulatory metabolizmu. In: Druga twarz tlenu. PWN, Warszawa, 283-286.
4. Bidere N, Senik A (2001) Caspase-independent apoptotic pathways in T lympocytes: a minireview. Apoptosis 6: 371-375.
5. Bijl M, Horst G, Limburg PC, Kallenberg CG (2001) Fas expression on peripheral blood lymphocyts in systemic lupus erythematosus (SLE): relation to lymphocyte activation and disease activity. Lupus 10: 866-872.
6. Boni R, Wellmann A, Man YG, Hofbauer G, Brinkmann U (1999) Expression of the proliferation and apoptosis-associated CAS protein in benign and malignant cutaneous melanocytic lesions. Amer J Dermatopathol 21: 125-128.
7. Chora̧ży M, Szala S (1998) Udzial genów w procesie nowotworzenia. In: Genetyka molekularna. PWN Warszawa, 385-411.
8. Courtney PA, Crockard AD, Williamson K, Irvine AE, Kennedy RJ, Bell AL. (1999) Increased apoptotic peripheral blood neutrophils in systemic lupus erythematosus: relation with disease activity, antibodies to double stranged DNA, and neutropenia. Ann Rheum Dis 58: 309-314.
9. Coven TR, Walters IB, Cardinale I, Krueger JG (1999) PUVA- induced lyphocyte apoptosis: machanism of action in psoriasis. Photodermatol Photoimmunol Photomed 15: 22-27.
10. Czarny M, Rutkowski R, Skrobisz J, Goździcka-Józefiak A, Wiktorowicz K (1998) Indukcja apoptozy w ludzkich limfocytach krwi obwodowej przez glikokortykosteroidy. Nowiny Lek 67: 355-366.
11. Czuwara J, Makieła B, Nowicka U, Barusińska A, Górkiewicz-Petkow A, Majewski S, Jablońska S, Rudnicka L (1996) Apoptoza w komórkach jednojadrowych krwi obwodowe pacjentów z twardzina̧ układowa̧. Przegl. Dermatol 83: 461-466.
12. Daugas E, Nochy D, Ravagnan L, Loeffler M, Susin SA, Zamzami N, Kroemer G (2002) Apoptosis-inducing factor (AIF) a ubiquitous mitochondrial oxidoreductase involved in apoptosis. FEBS Lett 476: 118-123.
13. Daugas E, Susin SA, Zamzami N, Ferri KF, Irinopoulou T, Larochette N, Prevost MC, Leber B, Andrews D, Penninger J, Kroemer G (2002) Mitochondria-nuclear translocation of AIF in apoptosis and necrosis. FASEB J 14: 729-739.
14. Delehedde M, Cho SH, Sarkiss M, Brisbay S, Davies M, El-Naggar AK, McDonnel TJ (1999) Altered expression of bcl-2 family member proteins in nonmelanoma skin cancer. Cancer, 85: 1514-1522.
15. Feleszko W (1998) Dojrzewanie limfocytów. In: Jakóbisiak M (ed) Immunologia. PWN, Warszawa, pp 121-140.
16. Genini, Sheeter D, Rought S, Zaunders JJ, Susin SA, Kroemer G, Richman DD, Carson DA, Corbeil J, Leoni LM (2001) HIV induces lymphocyte apoptosis by p-53-initiated mechanism. FASEB J 15: 5-6.
17. Grzela T, Oldak M, Jóźwik J, Malejczyk J (1999) Indukcja apoptozy przez receptory dla czynników z rodziny TNF. Post Hig Med Dośw 53: 351-363.
18. Guo Y, Shrinivasula SM, Druilhe A, fernandes-Alnemri T, Alnemri ES (2002) Caspase-2 induces apoptosis by releasing proapoptotic proteins from mitochondria. J Biol Chem 10: 1074-1080.
19. Hashimoto K (1976): Apoptosis in lichen planus and several other dermatoses Intra-epidermal cell death with filamentous degeneration. Acta Derm Venerol 56: 187-210.
20. Herr I, Debatin KM (2001): Cellular stress response and apoptosis in cancer theraty. Blood 98: 2603-2614.
21. Herrmann M, Voll RE, Zolter OM, Hegenhofer M, Ponner BB, Kalden JR (1998) Impaired phagocytosis of apoptotic cell material by monocyte-derived macrodhages from patients with systemic lupus erythematosus. Arthritis Rheum 41: 1241-1250.
22. Hishikawa K., Nakaki T, Fujii T (2000): Connective tissue growth factor induces apoptosis via caspase 3 in cultured human aortic smooth muscle cells. Europ J Pharmacol 392: 19-22.
23. Huck S, Jamin C, Youinou P, Zouali M (1998) High-density expression of CD95 on B cells and underrepresentation of B-1 cell subset in human lupus. Lupus 11: 449-455.
24. Jajte J (1998) Udzial rodników tlenowych w apoptozie - znaczenie kliniczne. Probl Terapii Monit 9: 3-8.
25. Jakóbisiak M (1998) Morfologia układu limfatycznego. In: Jakóbisiak M (ed) Immunologia. PWN, Warszawa, pp 33-56.
26. Jakóbisiak M (1998) Populacje i subpopulacje limfocytów. In: Jakóbisiak M (ed) Immunologia. PWN, Warszawa, pp 141-152.
27. Jarza̧b B (2001) Nowotwory. In: Patofizjologia. Volumed, Wrocław, 31-76.
28. Jendryczko A (1995) Apoptoza - kontrolowana śmierć komórki. Post Nauk Med 8: 267-270.
29. Jones PA (2001) Death and metylation. Nature 409: 141-144
30. Joza N, Susin SA, Daugas E, Stanford WL, Cho SK, Li CY, Sasaki T, Elia AJ, Cheng HY, Ravagnan L, Ferri KF, Zamzami N, Wakeham A, Hakem R, Yoshida H, Kong YY, Mak TW, Zuniga-Pflucker JC, Kroemer G, Penninger JM (2001) Essential role of the mitochondrial apoptosis-inducinf factor in programmed cell death. Nature 41: 549-554.
31. Kannan K, Jain SK (2000) Oxidative stress and apoptosis. Pathophysiol, 7: 153-163.
32. Karaś Z, Rutkowski R, Zabel J (1998) Cytometria przepływowa w diagnostyce tocznia rumieniowatego - badania wstȩpne. Nowiny Lek 67: 412-415.
33. Kerr JFR (1971) Apoptosis. J Pathol, 105: 13-17.
34. Klimiuk PA, Bernacka K, Kuryliszyn-Moskal A (1995) Zaburzenia regulacji apoptozy a choroby autoimmunologiczne. Reumatologia 33: 54-58.
35. Klupa T (1998) Apoptoza - od teorii do praktyki. Przegl Lek 55: 528-531.
36. Laporte M, Galand P, Fokan D, de Graef C, Heenen M (2000) Apoptosis in estabilished and healing psoriasis. Dermatol 200: 314-316.
37. Li G, Tang L, Zhou X, Tron V, Ho V (1998) Chemotherapy-induced apoptosis in melanoma cells is p53 dependent. Melanoma Research 8: 17-23.
38. Loeffler M, Daugas E, Susin SA, Zamzami N, Metiver D, Nieminen AL, Brothers G, Penninger JM, Kroemer G (2001) Dominant cell death induction by extra-mitochondrially targeted apoptosis-inducing factor. FASEB J 15: 758-767.
39. Lorenz HM, Hermann M, Kalden JR (2001) The pathogenesis of autoimmune diseases. Scand J Clin Lab (Suppl) 235: 16-26.
40. Lorenzo HK, Susin S.A., Penninger J, Kroemer G (1996) Apoptosis inducinf factor (AIF): a phylogenetically old, casase-independent effector of cell death. Cell Death Differ 6: 516-524.
41. Makino T, tabete S, Goto A, Mihara M, Ito H (1998) Apoptosis and cellular proliferation in human epidermal squamos cell neoplasia. J Cutan Pathol 25: 136-142.
42. Malejczyk J (1998) Mechanizmy cytotoksyczności limfocytów. In: Jakóbisiak M (ed) Immunologia. PWN, Warszawa, pp 323-335.
43. Martinou JC (1999) Key to the mitochondrial gate. Nature 399: 411-412.
44. Maślińska D (1997) Rola apoptozy w chorobach reumatycznych. Reumatol 35: 350-352.
45. Maślińska D (1999) Programowana śmierć komórki (apoptoza) w procesie zapalnym. Nowa Medycyna - Reumatologia IV 95: 12-20.
46. Matsuyama S, Reed JC (2000) Mitochondria-dependent apoptosis and cellular pH regulation. Cell Death Differ 7: 1155-1165.
47. Mehmet H (2000) Caspases find a new place to hide. Nature 403: 29-30.
48. Miramar MD, Costantini P, Ravagnan L, Saraiva LM, Haouzi D, Brothers G, Penninger JM, Peleato ML, Kroemer G, Susin (2001) NADH oxidase activity of mitochondrial apoptosis-inducing factor. J Biol Chem 276: 16391-16398.
49. Miret C, Font J, Molina R, Garcia-Garrasco M, Filella X, Ramos M, Cervera R, Ballesta A, Ingelmo M (2001) Relationship of oncogenes (sFas, Bcl-2) and cytokines (II-10, Alfa TNF) with the activity of systemic lupus erythematosus Anticancer Res 21 (4B): 3053-3059.
50. Motyl T (1999) Regulation of apoptotis: involvement of Bcl-2 related proteins. Reprod Nutr Dev 39: 49-59.
51. Nakagawa T., Zhu H, Morishima N., Li E, Xu J, Yanker B, Yuan J (2000) Caspase-12 mediates endoplasmic-reticulum-specific apoptosis by amyloid-b. Nature 403: 98-103.
52. Nevala H, Karenko L, Vakeva L, Ranki A (2001) Proapoptotic and antiapoptotic markers in cutaneous T-cell lymphoma skin infiltrates and lymphomatoid papulosis. British J Dermatol 145: 928-937.
53. Oldak M, Malejczyk J (1995) Mechanizmy przekazywania sygnałów przez receptor dla naskórkowego czynnika wzrostu (EGFR) oraz ich rola w regulacji apoptozy. Post Hig Med Dośw 53: 315-329.
54. Ostrowski K (1996) Indukowana apoptoza w leczeniu i zapobieganiu nowotworom. Medycyna na swiecie, 4: 10-11.
55. Papo T, Parizot C, Ortova M, Piette JC, Frances C, Debre P, Godeau P, Gorochov G (1998) Apoptosis and expression of soluble Fas mRNA in systemic lupus erythematosus. Lupus 7: 455-461.
56. Roliński J (1997) Apoptoza w układzie odpornościowym - rola Fas, bcl-2 i interleukiny 2. Post Biol Kom 24: 561-574.
57. Ruckert R, Asadullah K, Seifert M, Budagian VM, Arnold R, Trombotto Bulfone-Paus S (2000) Inhibition of keratinocyte apoptosis by IL-15: a new parameter in the pathogenesis of psoiasis. J Immunol 165: 2240-2250.
58. Rupniewska ZM, Rożynkowa D, Kurowsa M. (1997) Rodzina genów bcl-2. Post Biol Kom, 24: 33-47.
59. Shimizu S, Narita M, Tsujimoto Y (1999) Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial chanel VDAC. Nature 399: 483-487.
60. Shindo Y, Hashimoto T (1998) Ultraviolet B-induced cell death in four cutaneous cell lines exhibiting different enzymatic antioxidant defences: involvement of apoptosis. J Dermatol Sci 17: 140-150.
61. Simon K, Knysz B (1999) Znaczenia apoptozy w zakażeniach HIV/AIDS i wybranych chorobach zakaźnych. Problemy HIV i AIDS 5: 75-78.
62. Soengas M, Capodleci P, Polsky D, Mora J, Esteller M, Opitz-Araya X, McCombie R, Herman J, Gerald W, Lazebnik YA, Cordon-Cardo C, Lowe SW (2001) Inactivation of the apoptosis effector Apaf-1 in malignant melanoma. Nature 409: 207-211.
63. Srebro Z, Lach H (2000) Genetyczne, epigenetyczne i bioenergetyczne mechanizmy starzenia siȩ i nowotworów. Wyd. UJ. Kraków.
64. Staibano S, Lo Muzio L, Mezza E, Argenziano G, Tornillo L, Pannone G, De Rosa G (1999) Prognostic value of apoptotis index in cutaneous basal cell carcinomas of head and neck. Oral Oncology 35: 541-547.
65. Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, Mangion J, Jacobot E, Constantini P, Loeffler M, Larochette N, Goodlett DR, Aebersold R, Siderovski DP, Penninger JM, Kroemer G (1999) Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397: 441-446.
66. Szabo I, Tarnawski AS (2000) Apoptosis in the gastric mucosa: molecular mechanism, basic and clinical implications. J Physiol and Pharmacol 51: 13-15.
67. Tomkova H, Fujimoto W, Arata J (1998) Expression of the bcl-2 homoloque bax in normal human skin, psoriasis vulgaris and non-melanoma skin cancers. Eur J Dermatol 8: 256-260.
68. Trafna R (1995) Apoptoza, jej rola w kancerogenezie i terapii nowotworów. Przegl Dermatol 82: 241-247.
69. Tsujimoto Y (1998) Role of Bcl-2 family proteins in apoptosis: apoptosomes or mitochondria. Genes Cells 3: 697-707.
70. Vaishnaw AK, Toubi E, Ohsako S, Drappa J, Buys S, Estrada J, Sitarz A, Zemel L, Chu JL, Elkon KB (1999) The spectrum of apoptotic defects and clinical manifestations, including systemic lupus erythematosus, in human with CD 95 (Fas/APO-1) mutations. Arthritis Rheum 42: 1833-1842.
71. Wańkowicz A, Cwalina A (1998) Zjawiska immunologiczne. In: Jakóbisiak M (ed) Immunologia. PWN, Warszawa, pp 496-524.
72. Zagożdżon R (1998) Aktywacja limfocytów. In: Jakóbisiak M (ed) Immunologia. PWN, Warszawa, pp 241-262.
73. Zeman K (1998) Rola neutrofilów w procesach zapalnych. In: Zapalenie. Patofizjologia i klinika. Medpress, Warszawa, pp 76-97.
74. Żachowska-Wachelko B (2001) Patofizjologia wieku podesztego. In: Patofizjologia. Volumed, Wrocław, pp 447-466.